Application | Comment | Organism |
---|---|---|
medicine | enzyme is potential target for antimicrobial drugs | Escherichia coli |
Cloned (Comment) | Organism |
---|---|
recombinant large scale expression in strain BL21(DE3) | Escherichia coli |
Crystallization (Comment) | Organism |
---|---|
enzyme in open and closed form, 30 mg/ml purified recombinant enzyme in 10 mM Tris, pH 7.4, 40 mM KCl, with equal volume of reservoir solution, 0.006 ml sitting drops by vapour diffusion utilizing micro-bridges, 20% v/v ethylene glycol, 4°C, X-ray diffraction structure determination and analysis at 1.95 A and 1.6 A resolution, respectively, modeling | Escherichia coli |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-4-aspartyl phosphate + NADPH | Escherichia coli | part of the biosynthetic aspartate pathway | L-aspartate-4-semialdehyde + phosphate + NADP+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Escherichia coli | P0A9Q9 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant enzyme from strain BL21(DE3) in several steps | Escherichia coli |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-4-aspartyl phosphate + NADPH | part of the biosynthetic aspartate pathway | Escherichia coli | L-aspartate-4-semialdehyde + phosphate + NADP+ | - |
? | |
L-4-aspartyl phosphate + NADPH | reductive dephosphorylation | Escherichia coli | L-aspartate-4-semialdehyde + phosphate + NADP+ | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | crystal structure, subdomain structure of subunits, open and closed enzyme forms | Escherichia coli |
Synonyms | Comment | Organism |
---|---|---|
aspartate beta-semialdehyde dehydrogenase | - |
Escherichia coli |
ecASADH | - |
Escherichia coli |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADPH | - |
Escherichia coli |